ADMS
Adamas Pharmaceuticals
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
117 hedge funds and large institutions have $702M invested in Adamas Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 33 increasing their positions, 33 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
23% more funds holding
Funds holding: 95 → 117 (+22)
0% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 33
Holders
117
Holding in Top 10
6
Calls
$8.83M
Puts
$2.81M
Top Buyers
| 1 | +$58M | |
| 2 | +$42.7M | |
| 3 | +$37.4M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$14.8M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$7.36M |
Top Sellers
| 1 | -$23.1M | |
| 2 | -$22.4M | |
| 3 | -$20.5M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$16.6M |
| 5 |
AC
Armistice Capital
New York
|
-$15.9M |